miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Subjects:

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Subjects:

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Effect of SNX5 S226 phosphorylation on the retrograde transport of CI-M6PR. by Nao Itai (5954666)

Subjects:

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Subjects:

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Fig 5 - by Yong-Rae Kim (19797278)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

Subjects:

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Anatomical confirmation of drug injection sites. by Diana Amorim (662998)

“…<p>Schematic representation of the injection sites in the dorsomedial nucleus of the hypothalamus (DMH) (<b>A-D</b>: -3.00 mm, -3.12 mm, -3.24 mm and -3.36 mm from bregma) and medullary dorsal reticular nucleus (DRt) (<b>E-H</b>: -13.92 mm, -14.04 mm, -14.16 and -14.28 mm from bregma) of SHAM (light dots; n = 7) and ARTH (dark dots; n = 5). …”

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

Klotho decreased the expression of CHOP in mouse heart. by Shuang Song (457799)

BRCA1 silencing decreases cell viability. by Pei Chen (252989)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”